Evenity 105Mg/1.17Ml (90Mg/ml) 2 Injection
Regular price
167.440
KWD
Sale price
167.440
KWD
Regular price
KWD
KWD
/
Bone Strength
Rapid Relief
Fracture Defense
Targeted Action
Long-Lasting
-
USA
-
Romosozumab
EVENITY is a sclerostin inhibitor indicated for the treatment of osteoporosis
in postmenopausal women at high risk for fracture, defined as a history of
osteoporotic fracture, or multiple risk factors for fracture; or patients who
have failed or are intolerant to other available osteoporosis therapy.
in postmenopausal women at high risk for fracture, defined as a history of
osteoporotic fracture, or multiple risk factors for fracture; or patients who
have failed or are intolerant to other available osteoporosis therapy.